Bootstrap Representation Learning for Segmentation on Medical Volumes and Sequences

TL;DR

This paper introduces a bootstrap self-supervised learning method for medical volume and sequence segmentation that leverages local and global context, improving performance with limited annotations.

Contribution

It proposes a novel SSL approach using dense supervision and an attention-guided predictor tailored for volume and sequence data, outperforming existing methods.

Findings

Achieved 4.5% DSC improvement on ACDC dataset

Outperformed existing methods on Prostate and CAMUS datasets

Demonstrated effectiveness of local-global context exploitation

Abstract

In this work, we propose a novel straightforward method for medical volume and sequence segmentation with limited annotations. To avert laborious annotating, the recent success of self-supervised learning(SSL) motivates the pre-training on unlabeled data. Despite its success, it is still challenging to adapt typical SSL methods to volume/sequence segmentation, due to their lack of mining on local semantic discrimination and rare exploitation on volume and sequence structures. Based on the continuity between slices/frames and the common spatial layout of organs across volumes/sequences, we introduced a novel bootstrap self-supervised representation learning method by leveraging the predictable possibility of neighboring slices. At the core of our method is a simple and straightforward dense self-supervision on the predictions of local representations and a strategy of predicting locals based on global context, which enables stable and reliable supervision for both global and local representation mining among volumes. Specifically, we first proposed an asymmetric network with an attention-guided predictor to enforce distance-specific prediction and supervision on slices within and across volumes/sequences. Secondly, we introduced a novel prototype-based foreground-background calibration module to enhance representation consistency. The two parts are trained jointly on labeled and unlabeled data. When evaluated on three benchmark datasets of medical volumes and sequences, our model outperforms existing methods with a large margin of 4.5\% DSC on ACDC, 1.7\% on Prostate, and 2.3\% on CAMUS. Intensive evaluations reveals the effectiveness and superiority of our method.